Ignite Creation Date:
2025-12-24 @ 2:51 PM
Ignite Modification Date:
2026-01-17 @ 12:12 PM
Study NCT ID:
NCT02356159
Status:
COMPLETED
Last Update Posted:
2025-09-30
First Post:
2015-02-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-03-25
Completion Date Type:
ACTUAL
First Submit Date:
2015-02-04
First Submit QC Date:
None
Study First Post Date:
2015-02-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2025-04-10
Results First Submit QC Date:
None
Results First Post Date:
2025-06-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-11
Last Update Post Date:
2025-09-30
Last Update Post Date Type:
ESTIMATED